Display options
Cite
Bebb RA, Sirrs SM. DHEA: panacea or snake oil?. Can Fam Physician. 1999;45:1723-8
Bebb, R. A., & Sirrs, S. M. (1999). DHEA: panacea or snake oil?. Canadian family physician Medecin de famille canadien, 451723-8.
Bebb, R A, and Sirrs, S M. "DHEA: panacea or snake oil?." Canadian family physician Medecin de famille canadien vol. 45 (1999): 1723-8.
Bebb RA, Sirrs SM. DHEA: panacea or snake oil?. Can Fam Physician. 1999 Jul;45:1723-8. PMID: 10424272; PMCID: PMC2328381.
Copy Download .nbib Format: NLM
Share it on
Full text links
PubMed Central Free PMC Article

Can Fam Physician. 1999 Jul;45:1723-8.

DHEA: panacea or snake oil?.

Canadian family physician Medecin de famille canadien

R A Bebb, S M Sirrs

Affiliations

  1. Division of Endocrinology, University of British Columbia.

PMID: 10424272 PMCID: PMC2328381
Free PMC Article

Abstract

OBJECTIVE: To review the evidence that supplementation with dehydro-3-epiandrosterone (DHEA) is beneficial in aging, cardiovascular disease, immune function, and cancer.

METHODS: English-language literature search using MEDLINE with subject headings DHEA, adrenal steroids, and androgens.

QUALITY OF EVIDENCE: Although some randomized, double-blind, placebo-controlled trials have been conducted, most of the evidence supporting use of DHEA for any disease state is of poor quality and consists of case reports and case-control and open-label clinical trials.

MAIN MESSAGE: Dehydro-3-epiandrosterone is available as a health food supplement and is touted as being beneficial for a variety of diseases. It might be beneficial for improving someone's sense of well-being; minor improvements in body composition have been noted for men only. No consistent relationship has been demonstrated between levels of DHEA and risk of cardiovascular disease, breast cancer, or immune function. Insufficient evidence exists to support using DHEA for acquired immune deficiency syndrome. High levels of DHEA are associated with adverse effects, such as increased risk of breast and ovarian cancer at certain ages and reduced levels of high-density lipoprotein cholesterol.

CONCLUSIONS: Current enthusiasm for using DHEA as a panacea for aging, heart disease, and cancer is not supported by scientific evidence in the literature. Given the potentially serious adverse effects, using DHEA in the clinical setting should be restricted to well-designed clinical trials only.

Cited by

References

  1. J Infect Dis. 1991 Nov;164(5):864-8 - PubMed
  2. J Infect Dis. 1992 Mar;165(3):413-8 - PubMed
  3. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  4. Circulation. 1994 Jan;89(1):89-93 - PubMed
  5. J Clin Endocrinol Metab. 1994 Jun;78(6):1360-7 - PubMed
  6. Lancet. 1994 Jun 11;343(8911):1479-81 - PubMed
  7. Atherosclerosis. 1994 Feb;105(2):191-200 - PubMed
  8. Arthritis Rheum. 1994 Sep;37(9):1305-10 - PubMed
  9. J Clin Endocrinol Metab. 1994 Oct;79(4):1086-90 - PubMed
  10. Circulation. 1995 Mar 15;91(6):1757-60 - PubMed
  11. JAMA. 1995 Dec 27;274(24):1926-30 - PubMed
  12. Arthritis Rheum. 1995 Dec;38(12):1826-31 - PubMed
  13. J Clin Endocrinol Metab. 1996 Jan;81(1):59-64 - PubMed
  14. Ann N Y Acad Sci. 1995 Dec 29;774:111-20 - PubMed
  15. Ann N Y Acad Sci. 1995 Dec 29;774:128-42 - PubMed
  16. J Clin Endocrinol Metab. 1996 Sep;81(9):3147-51 - PubMed
  17. Diabetes Care. 1996 Oct;19(10):1045-50 - PubMed
  18. JAMA. 1996 Nov 6;276(17):1365-7 - PubMed
  19. Biol Psychiatry. 1997 Feb 1;41(3):311-8 - PubMed
  20. Ann Pharmacother. 1997 May;31(5):639-42 - PubMed
  21. J Am Geriatr Soc. 1997 Jun;45(6):747-51 - PubMed
  22. J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402 - PubMed
  23. Cancer Res. 1981 Sep;41(9 Pt 1):3360-3 - PubMed
  24. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  25. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  26. J Clin Endocrinol Metab. 1988 Jan;66(1):57-61 - PubMed
  27. Cancer Res. 1990 Jul 1;50(13):3859-62 - PubMed
  28. Int J Obes. 1990 May;14(5):457-63 - PubMed
  29. Semin Oncol. 1990 Aug;17(4):438-55 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources